Literature DB >> 216752

Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression.

D Mayo, J A Armstrong, M Ho.   

Abstract

No free virus was detectable in any organ of DBA/2 mice greater than or equal to 16 weeks after infection with murine cytomegalovirus. Spleens were free of free lytic virus six weeks after infection. Spleen cells from such mice were shown to be latently infected by three methods. First, virus was recovered by cocultivation of spleen cells for two weeks or longer on either syngeneic or allogeneic (CDI) embryonic fibroblast cultures. Second, virus was recovered from salivary glands of either syngeneic (DBA/2) or allogeneic (C57BL/10) mice that received 10(8) spleen cells. Recovery was enhanced by treatment of allogeneic recipients with cyclophosphamide but not with azathioprine. Third, latently infected mice, after treatment with either cyclophosphamide or azathioprine, developed free murine cytomegalovirus in their salivary glands. The last two findings parallel observations of human cytomegalovirus in immunosuppressed patients and in patients receiving latently infected cells during transplantation. Both cyclophosphamide and azathioprine elevated titers of free lytic virus in the salivary glands.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216752     DOI: 10.1093/infdis/138.6.890

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Animal cytomegaloviruses.

Authors:  J Staczek
Journal:  Microbiol Rev       Date:  1990-09

2.  DMSO induces reactivation of cytomegalovirus in vitro from spleens of latently infected mice. Brief report.

Authors:  S Blackett; A Gupta; C A Mims
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

3.  Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency.

Authors:  M Hummel; Z Zhang; S Yan; I DePlaen; P Golia; T Varghese; G Thomas; M I Abecassis
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Cytomegalovirus-specific cytotoxicity mediated by non-T lymphocytes from peripheral blood of normal volunteers.

Authors:  N Kirmani; R K Ginn; K K Mittal; J F Manischewitz; G V Quinnan
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

5.  Effects of immunosuppression with cyclophosphamide on acute murine cytomegalovirus infection and virus-augmented natural killer cell activity.

Authors:  M K Selgrade; M J Daniels; P C Hu; F J Miller; J A Graham
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

6.  Spontaneous activation of latent cytomegalovirus from murine spleen explants. Role of lymphocytes and macrophages in release and replication of virus.

Authors:  M C Jordan; V L Mar
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

7.  Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping.

Authors:  M Gao; H C Isom
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

8.  Latency, without persistence, of murine cytomegalovirus in the spleen and kidney.

Authors:  J L Pollock; H W Virgin
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

9.  Adverse effects of cytomegalovirus vaccination in mice.

Authors:  M C Jordan
Journal:  J Clin Invest       Date:  1980-04       Impact factor: 14.808

10.  Latent murine cytomegalovirus DNA in splenic stromal cells of mice.

Authors:  C Pomeroy; P J Hilleren; M C Jordan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.